180 Life Sciences Corp. - notizie pubblicate 234 - letture 8.933


180 Life Sciences Corp.

180 LIFE SCIENCES CORP.

Annual Report for Fiscal Year Ending December 31, 2023 (Form 10-K)

United states securities and exchange commission washington, d.c. 20549 form 10-k (mark one) ☒annual report pursuant to section 13 or 15(d) of the securities exchange act of 1934 ...

25.03.2024
180 Life Sciences Corp.

180 LIFE SCIENCES CORP.

Corporate Presentation

Nasdaq: atnf leading research into solving one of the world's largest drivers of disease: inflammation corporate presentation march 2024 disclaimer this presentation is for informa ...

15.03.2024
180 Life Sciences Corp.

180 LIFE SCIENCES CORP.

180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price Requirement

180 life sciences regains full compliance with nasdaq minimum bid price requirement march 14, 2024 8:30am edt download as pdf palo alto, calif., march 14, 2024 (globe newswire) -- ...

14.03.2024
180 Life Sciences Corp.

180 LIFE SCIENCES CORP.

Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price Requirement - Form 8-K

180 life sciences regains full compliance with nasdaq minimum bid price requirement palo alto, calif., march 14, 2024 -- 180 life sciences corp. (nasdaq: atnf) ("180 life scie ...

14.03.2024
180 Life Sciences Corp.

180 LIFE SCIENCES CORP.

Initial Statement of Beneficial Ownership - Form 3

Ownership submission form 3 united states securities and exchange commission washington, d.c. 20549initial statement of beneficial ownership of securities filed pursuant to section ...

12.03.2024
180 Life Sciences Corp.

180 LIFE SCIENCES CORP.

Initial Statement of Beneficial Ownership - Form 3

Ownership submission form 3 united states securities and exchange commission washington, d.c. 20549initial statement of beneficial ownership of securities filed pursuant to section ...

11.03.2024
180 Life Sciences Corp.

180 LIFE SCIENCES CORP.

Initial Statement of Beneficial Ownership - Form 3

Ownership submission form 3 united states securities and exchange commission washington, d.c. 20549initial statement of beneficial ownership of securities filed pursuant to section ...

11.03.2024
180 Life Sciences Corp.

180 LIFE SCIENCES CORP.

Management Change/Compensation - Form 8-K

Item 5.02 departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers. (b) resignation of dire ...

11.03.2024
180 Life Sciences Corp.

180 LIFE SCIENCES CORP.

Private Placement - Form 8-K

Item 3.02. unregistered sales of equity securities. on march 6, 2024 and march 7, 2024, the holder of pre-funded warrants to purchase 1/19th of a share of common stock of 180 life ...

08.03.2024
180 Life Sciences Corp.

180 LIFE SCIENCES CORP.

Private Placement - Form 8-K

Item 3.02. unregistered sales of equity securities. on february 28, 2024, the holder of pre-funded warrants to purchase shares of common stock of 180 life sciences corp. (the " ...

01.03.2024
180 Life Sciences Corp.

180 LIFE SCIENCES CORP.

Management Change/Compensation - Form 8-K

Item 5.02 departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers. (d) appointment of new ...

29.02.2024
180 Life Sciences Corp.

180 LIFE SCIENCES CORP.

Supplemental Prospectus - Form 424B3

Filed pursuant to rule 424(b)(3) registration no. 333-272749 prospectus supplement no. 4 (to prospectus dated august 9, 2023) 666,925 shares of common stock pre-funded warrants to ...

28.02.2024
180 Life Sciences Corp.

180 LIFE SCIENCES CORP.

Supplemental Prospectus - Form 424B3

Filed pursuant to rule 424(b)(3) registration no. 333-276796 prospectus supplement no. 2 (to prospectus dated february 9, 2024) 13,950,976 shares of common stock this prospectus su ...

28.02.2024
180 Life Sciences Corp.

180 LIFE SCIENCES CORP.

Supplemental Prospectus - Form 424B3

Filed pursuant to rule 424(b)(3) registration no. 333-271703 prospectus supplement no. 5 (to prospectus dated may 12, 2023) 4,448,713 shares of common stock this prospectus supplem ...

28.02.2024
180 Life Sciences Corp.

180 LIFE SCIENCES CORP.

180 Life Sciences Corp. Announces 1-For 19 Reverse Stock Split as Part of Nasdaq Compliance Plan

180 life sciences corp. announces 1-for 19 reverse stock split as part of nasdaq compliance plan february 26, 2024 7:00am est download as pdf palo alto, calif., feb. 26, 2024 (glob ...

26.02.2024
Condividi